VANCOUVER, June 15, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the "Company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the appointment of Mr. Alan Rootenberg as Chief Financial Officer, effective June 14, 2022. The Company thanks Mr. Oded Gilboa for his contribution to the Company, as CFO. Mr. Gilboa has also left his role as a director of the company.
Read more at globenewswire.comClearmind Medicine Appoints New Chief Financial Officer
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/A%20concept%20image%20of%20space_%20Image%20by%20Canities%20via%20Shutterstock_.jpg)
/A%20concept%20image%20of%20a%20flying%20car_%20Image%20by%20Phonlamai%20Photo%20via%20Shutterstock_.jpg)
